Dr. Susan H Land, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Mount Pleasant Rd, Thomson, GA 30824 Phone: 706-595-1461 Fax: 706-597-9824 |
Ms. Kelli M Carter, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1113 Washington Rd, Thomson, GA 30824 Phone: 706-595-7825 Fax: 706-595-1235 |
Roger F. Nelson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Fluker St, Thomson, GA 30824 Phone: 706-595-1090 Fax: 706-595-6010 |
Dr. Holly Barmore Mahoney, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Mount Pleasant Rd, Thomson, GA 30824 Phone: 706-595-1461 |
Dr. Daryl Carson Wiley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Fluker St, Thomson, GA 30824 Phone: 706-595-1090 Fax: 706-595-6010 |
Dr. Tyler J Provost, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2508 University Dr, Thomson, GA 30824 Phone: 706-595-1090 Fax: 706-595-6010 |
Dr. Kristina Lynn Kruse, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Mount Pleasant Rd, Thomson, GA 30824 Phone: 706-595-1461 Fax: 706-597-9824 |
Dr. James L Lemley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 505 Mount Pleasant Rd, Thomson, GA 30824 Phone: 706-595-1461 Fax: 706-597-9824 |
Merritt Echols Mclaughlin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Fluker Street Family Medicine, Thomson, GA 30824 Phone: 706-595-1090 Fax: 706-595-6010 |
News Archive
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), announced today that it was issued U.S. Patent No. 7,625,942, a "Method of Treating Down Syndrome" by the U.S. Patent and Trademark Office. The '942 patent covers use of Posiphen and analogs to treat cognitive impairments associated with Down Syndrome (DS). This patent valuably expands upon the original Posiphen and analog patent that claims composition of matter and use of compounds to lower amyloid-β precursor protein (APP) and thereby treat dementia and Alzheimer's disease (AD).
Depression is the leading cause of disability worldwide, striking as many as one in four women and one in eight men in their lifetime.
There may be new treatments for stroke, migraine, Alzheimer's and other brain disorders, thanks to the discovery of a mechanism for regulating brain blood flow made by researchers at the University of British Columbia.
With so few people affected by rare diseases, how does a group of less than 90 patients across Canada make their voices heardon a life-and-death issue such as access to treatment? Barry Katsof, President of the Canadian Association of PNH Patients, says his group is turning to social media to ask others to take a stand with them in the fight for their lives.
› Verified 6 days ago